These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23495233)

  • 1. New therapies for treating Down syndrome require quality of life measurement.
    Goodman MJ; Brixner DI
    Am J Med Genet A; 2013 Apr; 161A(4):639-41. PubMed ID: 23495233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New insights into the support of children with Down syndrome].
    Weijerman M; Broers CJ; van der Plas RN
    Ned Tijdschr Geneeskd; 2013; 157(6):A5330. PubMed ID: 23388138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down Syndrome Cures: Perspectives of People With Down Syndrome and Their Parents.
    Rogers JM; Weaver AL; Havyer RD
    Am J Intellect Dev Disabil; 2022 May; 127(3):194-212. PubMed ID: 35443053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome.
    Guedj F; Bianchi DW
    Prenat Diagn; 2013 Jun; 33(6):614-8. PubMed ID: 23595836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal therapy for Down syndrome: an ethical exploration.
    de Wert G; Dondorp W; Bianchi DW
    Prenat Diagn; 2017 Mar; 37(3):222-228. PubMed ID: 28004394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.
    Hamlett ED; Boger HA; Ledreux A; Kelley CM; Mufson EJ; Falangola MF; Guilfoyle DN; Nixon RA; Patterson D; Duval N; Granholm AC
    Curr Alzheimer Res; 2016; 13(1):35-52. PubMed ID: 26391050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down syndrome: genes, model systems, and progress towards pharmacotherapies and clinical trials for cognitive deficits.
    Busciglio J; Capone G; O'Bryan J; Gardiner KJ
    Cytogenet Genome Res; 2013; 141(4):260-71. PubMed ID: 24008277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular physiology and pathophysiology in Down syndrome.
    Cilhoroz BT; Receno CN; Heffernan KS; Deruisseau LR
    Physiol Res; 2022 Mar; 71(1):1-16. PubMed ID: 35043643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated care for Down syndrome.
    Lee NC; Chien YH; Hwu WL
    Congenit Anom (Kyoto); 2016 May; 56(3):104-6. PubMed ID: 26866291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
    Çağlayan ES
    Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care concerns and guidelines for adults with Down syndrome.
    van Allen MI; Fung J; Jurenka SB
    Am J Med Genet; 1999 Jun; 89(2):100-10. PubMed ID: 10559765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome: Neurobiological alterations and therapeutic targets.
    Vacca RA; Bawari S; Valenti D; Tewari D; Nabavi SF; Shirooie S; Sah AN; Volpicella M; Braidy N; Nabavi SM
    Neurosci Biobehav Rev; 2019 Mar; 98():234-255. PubMed ID: 30615933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenesis, Myelination, and Circuitry: The Case for a Distributed Therapeutic Regimen in Down Syndrome.
    Haydar TF
    Am J Intellect Dev Disabil; 2020 Mar; 125(2):100-102. PubMed ID: 32058811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis.
    Carmona-Iragui M; Videla L; Lleó A; Fortea J
    Dev Neurobiol; 2019 Jul; 79(7):716-737. PubMed ID: 31278851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care of Adults With Intellectual and Developmental Disabilities: Down Syndrome.
    Wilson B; Jones KB; Weedon D; Bilder D
    FP Essent; 2015 Dec; 439():20-5. PubMed ID: 26669211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a.
    Marechal D; Brault V; Leon A; Martin D; Lopes Pereira P; Loaëc N; Birling MC; Friocourt G; Blondel M; Herault Y
    Hum Mol Genet; 2019 May; 28(9):1561-1577. PubMed ID: 30649339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome.
    Lessov-Schlaggar CN; Del Rosario OL; Morris JC; Ances BM; Schlaggar BL; Constantino JN
    J Neurodev Disord; 2019 Dec; 11(1):39. PubMed ID: 31842726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments.
    Dierssen M; Ortiz-Abalia J; Arqué G; de Lagrán MM; Fillat C
    Behav Genet; 2006 May; 36(3):454-68. PubMed ID: 16520905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In search of quality indicators for Down syndrome healthcare: a scoping review.
    van den Driessen Mareeuw FA; Hollegien MI; Coppus AMW; Delnoij DMJ; de Vries E
    BMC Health Serv Res; 2017 Apr; 17(1):284. PubMed ID: 28420357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.